http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2007203592-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da04b40384f30a62c8c906c771d576f6 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate | 2007-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2011-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93a4ad99f01c85dc09c967578fc0deed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22b00c5e4868da91a553e27aa51f77f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1127882652fc6ec08a330993d3ce708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6114ca6e9d30a8a997c7fa67657a91c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf49f581ff98378b9f592992cc07cab7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dda8b2b096c61be3dfe4a2df9e65b353 |
publicationDate | 2011-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2007203592-B2 |
titleOfInvention | 36P6D5: Secreted tumor antigen |
abstract | Described is a gene and its encoded secreted tumor antigen, termed 36P6D5, and to diagnostic and therapeutic methods and compositions useful in the management of various cancers which express 36P6D5, particularly including cancers of the bladder, kidney, prostate, breast, colon, ovary and pancreas. 10 19 28 37 46 55 5' TGG CTG CGG TCG CCT GGG AGC TGC CGC CAG GGC CAG GAG GGG AGC GGC ACC TGG W L R S P G S C R 0 G Q E G S G T W 64 73 82 91 100 109 AAG ATG CGC CCA TTG GCT GGT GGC CTG CTC AAG GTG GTG TTC GTG GTC TTC GCC K M R P L A G G L L K V V F V V F A 118 127 136 145 154 163 TCC TTG TGT GCC TGG TAT TCG GGG TAC CTG CTC GCA GAG CTC ATT CCA GAT GCA S L C A W Y S G Y L L A E L I P D A 172 181 190 199 208 217 CCC CTG TCC AGT GCT GCC TAT AGC ATC CGC AGC ATC GGG GAG AGG CCT GTC CTC P L S S A A Y S I R S I G E R P V L 226 235 244 253 262 271 AAA GCT CCA GTC CCC AAA AGG CAA AAA TGT GAC CAC TGG ACT CCC TGC CCA TCT K A P V P K R Q K C D H W T P C P S 280 289 298 307 316 325 GAC ACC TAT GCC TAC AGG TTA CTC AGC GGA GGT GGC AGA AGC AAG TAC GCC AAA D T Y A Y RL L S G G G R S K Y A K 334 343 352 361 370 379 ATC TGC TTT GAG GAT AAC CTA CTT ATG GGA GAA CAG CTG GGA AAT GTT GCC AGA I C F E D N L L M G E Q L G N V A R 388 397 406 415 424 433 GGA ATA AAC ATT GCC ATT GTC AAC TAT GTA ACT GGG AAT GTG ACA GCA ACA CGA G I N I A I V N Y V T G N V T A T R 442 451 460 469 478 487 TGT TTT GAT ATG TAT GAA GGC GAT AAC TCT GGA CCG ATG ACA AAG TTT ATT CAG C F D M Y E G D N S G P M T K F I Q 496 505 514 523 532 541 AGT GCT GCT CCA AAA TCC CTG CTC TTC ATG GTG ACC TAT GAC GAC GGA AGC ACA S A A P K S L L F M V T Y D D G S T |
priorityDate | 1999-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 432.